Detection of Fas and its ligand, FasL, in mouse thymus by in situ hybridization

Thymus

Volumn 24, Issue 4, 1997, Pages 279-286

  Gffinau, Monika ^a   Hartmann, Klaus Ulrich ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Fas ligand; FasL

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA ANALYSIS; THYMUS; TISSUE DISTRIBUTION;

AGE FACTORS; ANIMALS; ANTIGENS, CD95; FAS LIGAND PROTEIN; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; RNA, MESSENGER; THYMUS GLAND;

EID: 0031422954     PISSN: 01656090     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016939410783     Document Type: Article

References (28)

1. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449.
2. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274.
3. Takahashi T, Tanaka, M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969.
4. Lagresle C, Mondiere P, Bella C, Krammer PH, Defrance T. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO1/Fas-mediated apoptosis. J Exp Med 1996; 183: 1377.
5. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806.
6. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL Ipr/lpr. Proc Natl Acad Sci USA 1993; 90: 10340.
7. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753.
8. Trauth BC, Klas C, Peters AMI, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301.
9. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Goldstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995; 181: 781.
10. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH. Differential ability of Tl and T/,2T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994; 6: 1545.
11. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169.
12. Ogasawara J, Suda T, Nagata S. Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med 1995; 181: 485.
13. Andjelic S, Drappa J, Lacy E, Elkon KB, Nikolic-Zugic J. The onset of Fas expression parallels the acquisition of CDS and CD4 in fetal and adult a thymocytes. Int Immunol 1994; 6: 73.
14. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, Ishii A. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 1994; 6: 1849.
15. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice. Proc Natl Acad Sci USA 1993; 90: 1756.
16. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314.
17. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993; 178: 461.
18. Singer GG, Abbas AK. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365.
19. Musette P, Pannetier C, Gachelin G, Kourilsky P. The expansion of a CD4+ T cell population bearing a distinctive chain in MRL Ipr/lpr mice suggest a role for the Fas protein in peripheral T cell selection. Eur J Immunol 1994; 24: 2761.
20. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune Ipr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993; 90: 4409.
21. Herren LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL. Selection of the T cell receptor repertoire in Ipr mice. J Immunol 1993; 151:3450.
22. Cohen PL, Eisenberg RA. The Ipr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today 1992; 13: 427.
23. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fasmediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184: 1075.
24. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
25. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
26. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Müller C, Tschopp J. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immuneprivileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol 1996; 133: 335.
27. Abbas AK. Die and let live: Eliminating dangerous lymphocytes. Cell 1996; 84: 655.
28. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935.